Latest period
$4.08B
YoY change
+13.8%
5Y CAGR
-5.0%
Peak year (2021)
$10.52B
Latest annual
$3.69B
Total Liabilities history chart for Moderna (MRNA) from 2016 to 2025
Latest: $3.69B
Total Liabilities growth chart for Moderna (MRNA) from 2016 to 2025
Latest: +13.8%
Total Liabilities history table for Moderna (MRNA) from 2016 to 2025
| 2025 | $3.69B | +13.8% | +$447.00M | ||
| 2024 | $3.24B | -29.1% | −$1.33B | ||
| 2023 | $4.57B | -32.1% | −$2.16B | ||
| 2022 | $6.74B | -36.0% | −$3.79B | ||
| 2021 | $10.52B | +120.4% | +$5.75B | ||
| 2020 | $4.78B | +1051.9% | +$4.36B | ||
| 2019 | $414.61M | -4.0% | −$17.30M | ||
| 2018 | $431.91M | -5.9% | −$27.29M | ||
| 2017 | $459.19M | -20.2% | −$116.12M | ||
| 2016 | $575.31M | — | — |
- 2025$3.69B+13.8%
- 2024$3.24B-29.1%
- 2023$4.57B-32.1%
- 2022$6.74B-36.0%
- 2021$10.52B+120.4%
- 2020$4.78B+1051.9%
- 2019$414.61M-4.0%
- 2018$431.91M-5.9%
- 2017$459.19M-20.2%
- 2016$575.31M—
Total Liabilities values are taken from Moderna's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported total liabilities is $4.08B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Moderna (MRNA) reported total liabilities of $3.69B – grew 13.8% year-over-year.
Through 2020–2025 (5 years), Moderna total liabilities delivered a -5.0% annualised rate; with a net decline across the window.
2021 marks the peak total liabilities at $10.52B, with the historical low of $414.61M recorded in 2019.
Moderna Total Liabilities by Year
Moderna Total Liabilities 2025: $3.69B
In 2025, Moderna reported total liabilities of $3.69B, grew 13.8% from 2024.
Moderna Total Liabilities 2024: $3.24B
Moderna total liabilities in 2024 was $3.24B, declined 29.1% below 2023.
Moderna Total Liabilities 2023: $4.57B
2023's total liabilities for Moderna came in at $4.57B, plunged 32.1% below 2022.
Moderna Total Liabilities 2022: $6.74B
Moderna posted total liabilities of $6.74B in 2022, plunged 36.0% below 2021.
Moderna Total Liabilities 2021: $10.52B
Moderna total liabilities in 2021 was $10.52B.
See more financial history for Moderna (MRNA).
Sector peers by Total Liabilities
Healthcare peers of Moderna (MRNA), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation